Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia

NCT04679415 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: hzVSF-v13
DRUG: Placebo (Normal saline solution)

Sponsor

ImmuneMed, Inc.